News and events

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced new, long-term results from its final report of the SPYRAL HTN-ON MED randomized clinical trial.

We are glad to inform you about the appearance of a new product from Meril Life Sciences - Obtura™ Vascular Closure Device.

We are pleased to announce the availability of new products from Meril Life Sciences - Lineage™ Rx PTCA and Lineage™ NC Rx PTCA balloon catheters.

Medtronic Evolut™ TAVR system shows durable clinical outcomes and outstanding valve performance at five years in low-risk aortic stenosis patients

SMART Trial two-year data continues to demonstrate superior valve performance for Evolut TAVR™ system in small annulus patients

SPYRAL HTN-ON MED study shows significant, consistent, long-term blood pressure lowering effect at two years